Maine Recalls Cannabis Products After Tests Find Unsafe Yeast, Mold
State regulators pulled multiple products from shelves after lab results showed contamination levels exceeding safety thresholds.

Scientist in protective gear handling powder sample in a sterile lab environment.
Contamination Triggers Statewide Product Pulls
Maine's Office of Cannabis Policy issued mandatory recalls after third-party lab testing found yeast and mold contamination exceeding the state's maximum allowable limits in multiple product batches. The contamination turned up during routine compliance testing required under Maine's adult-use and medical cannabis regulations. State rules mandate that all cannabis products undergo microbial screening before reaching consumers, with hard caps on total yeast and mold counts as well as specific pathogenic species.
The recalls were announced June 9. Officials haven't released the names of affected cultivators, product SKUs, or batch numbers. That opacity is standard practice in Maine during the initial recall phase, though the Office of Cannabis Policy typically publishes detailed recall notices within 72 hours on its public compliance dashboard. Dispensaries received direct notification and were instructed to remove affected inventory from shelves immediately.
Maine's microbial limits are among the strictest in the Northeast. The state caps total yeast and mold at 10,000 colony-forming units per gram and enforces zero-tolerance thresholds for pathogenic species including Aspergillus and Salmonella. Flower and concentrates face identical testing requirements, a contrast to states like Massachusetts where concentrate testing protocols differ.
Why Mold and Yeast Contamination Poses Health Risks
Yeast and mold in cannabis products present acute risks to immunocompromised patients, who make up a significant share of Maine's medical cannabis user base. Inhalation of mold spores can trigger allergic reactions, respiratory infections, and in severe cases aspergillosis—a potentially fatal lung infection caused by Aspergillus species. Medical patients undergoing chemotherapy, organ transplant recipients, and individuals with HIV or autoimmune conditions face elevated risk from even low-level contamination.
The contamination likely originated during cultivation or post-harvest handling. High humidity during flowering, inadequate airflow in drying rooms, or improper curing can all create conditions for mold colonization. Once established, mold persists through processing. Concentrates made from contaminated flower carry the same microbial load, and some extraction methods can concentrate fungal toxins rather than eliminate them.
Maine doesn't require irradiation or other post-harvest microbial remediation, a policy choice that keeps the state's testing-and-discard approach stricter than remediation-permitting jurisdictions like Nevada or Michigan. Contaminated batches are destroyed rather than salvaged. That's a financial hit for cultivators but a cleaner public-health outcome.
What Happens Next and Enforcement Uncertainty
The Office of Cannabis Policy will publish full recall details including cultivator names, batch IDs, and affected dispensaries within the next 72 hours, according to standard protocol. Consumers who purchased products during the affected window—likely late May through early June based on typical testing turnaround times—should monitor the OCP's public notices page and consult their dispensary for return or exchange instructions.
For background on Maine's testing regime and how it compares to other adult-use states, see the CannIntel topic hub on Maine's cannabis program. The state's microbial standards have been in place since the adult-use market launched in 2020, but enforcement intensity varies. Some cultivators report that testing labs differ in their interpretation of borderline results, particularly for total yeast and mold counts near the 10,000 CFU/g threshold.
This recall is the third microbial-related action in Maine in 2026, following a February incident involving Aspergillus in pre-rolls and an April recall tied to pesticide residues that also flagged mold. The pattern suggests either a cluster of environmental control failures among a subset of cultivators or heightened scrutiny from state-contracted testing labs. Enforcement will likely shift as Maine refines its compliance posture heading into the summer harvest cycle.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What cannabis products were recalled in Maine?
Maine's Office of Cannabis Policy recalled multiple batches of flower, concentrates, and infused products on June 9, 2026, after lab tests detected yeast and mold contamination exceeding state safety limits. Specific product names and brands have not yet been disclosed but are expected within 72 hours.
Why is mold in cannabis dangerous?
Mold contamination in cannabis poses serious health risks, especially to immunocompromised patients. Inhaling mold spores can cause allergic reactions, respiratory infections, and aspergillosis—a potentially fatal lung infection. Maine enforces strict microbial limits to protect medical patients undergoing chemotherapy or with weakened immune systems.
How does Maine test cannabis for contamination?
Maine requires all cannabis products to undergo third-party lab testing for microbial contamination before sale. The state caps total yeast and mold at 10,000 colony-forming units per gram and enforces zero tolerance for pathogens like Aspergillus and Salmonella. Contaminated batches must be destroyed; remediation methods like irradiation are not permitted.
What should Maine cannabis consumers do after this recall?
Consumers who purchased cannabis products in late May or early June 2026 should check the Office of Cannabis Policy's public notices page for updated recall details, including affected batch numbers and dispensaries. Contact your dispensary for return or exchange instructions if you purchased a recalled product.
How common are cannabis recalls in Maine?
This is the third microbial-related recall in Maine in 2026, following incidents in February and April. The frequency suggests either environmental control failures among some cultivators or increased enforcement scrutiny from state-contracted testing labs. Maine's microbial standards have been in place since the adult-use market launched in 2020.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from News

Cannabis Club Data Breach Exposes One Million Passport Records
Unsecured database containing customer passport scans and transaction logs left accessible for weeks before discovery.

Maine Recalls Cannabis Flower Strain Sold at Multiple Stores Statewide
State regulators pulled a cannabis flower product from shelves across Maine following safety concerns.

Ohio Medical Cannabis Dispensary Licenses Face New Delays
State regulators postpone license awards as application review drags into second quarter.
More from the newsroom

Bronx Dispensary Accused of Selling Unlicensed Cannabis Products
A Bronx cannabis retailer faces allegations of selling products without proper state authorization.

North Carolina House Passes Hemp Age Limit After Stalled Regulations
The NC House approved a standalone age-restriction bill after comprehensive hemp regulation efforts collapsed in the Senate.

Hempstead and Lake Success Consider Lifting Cannabis Opt-Out
Two Nassau County villages weigh reversing local bans on adult-use dispensaries.